本页面由Tiger Trade Technology Pte. Ltd.提供服务

Centessa Pharmaceuticals plc

28.70
-0.7000-2.38%
盘后28.00-0.7000-2.44%19:39 EDT
成交量:138.56万
成交额:4,042.64万
市值:41.90亿
市盈率:-15.76
高:29.93
开:29.35
低:28.68
收:29.40
52周最高:30.58
52周最低:9.60
股本:1.46亿
流通股本:9,712.58万
量比:0.82
换手率:1.43%
股息:- -
股息率:- -
每股收益(TTM):-1.8212
每股收益(LYR):-2.0595
净资产收益率:-60.62%
总资产收益率:-25.26%
市净率:13.89
市盈率(LYR):-13.94

数据加载中...

2026/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

重要事件披露

Form 8-K - Current report
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]